GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Kohjin Bio Co Ltd (TSE:177A) » Definitions » EBIT

Kohjin Bio Co (TSE:177A) EBIT : 円625 Mil (TTM As of Jun. 2024)


View and export this data going back to 2024. Start your Free Trial

What is Kohjin Bio Co EBIT?

Kohjin Bio Co's earnings before interest and taxes (EBIT) for the three months ended in Jun. 2024 was 円233 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Jun. 2024 was 円625 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Kohjin Bio Co's annualized ROC % for the quarter that ended in Jun. 2024 was 11.15%. Kohjin Bio Co's annualized ROC (Joel Greenblatt) % for the quarter that ended in Jun. 2024 was 26.49%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Kohjin Bio Co's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Jun. 2024 was 7.95%.

Kohjin Bio Co EBIT Historical Data

The historical data trend for Kohjin Bio Co's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Kohjin Bio Co EBIT Chart

Kohjin Bio Co Annual Data
Trend Mar22 Mar23 Mar24
EBIT
961.00 1,276.80 658.47

Kohjin Bio Co Quarterly Data
Mar22 Mar23 Dec23 Mar24 Jun24 Sep24
EBIT Get a 7-Day Free Trial - - 244.02 232.55 148.57

Competitive Comparison of Kohjin Bio Co's EBIT

For the Biotechnology subindustry, Kohjin Bio Co's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Kohjin Bio Co's EV-to-EBIT Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Kohjin Bio Co's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Kohjin Bio Co's EV-to-EBIT falls into.


';

Kohjin Bio Co EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Jun. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was 円625 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Kohjin Bio Co  (TSE:177A) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Kohjin Bio Co's annualized ROC % for the quarter that ended in Jun. 2024 is calculated as:

ROC % (Q: Jun. 2024 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Mar. 2024 ) + Invested Capital (Q: Jun. 2024 ))/ count )
=827.56 * ( 1 - 27.83% )/( (5357.373 + 0)/ 1 )
=597.250052/5357.373
=11.15 %

where

Invested Capital(Q: Mar. 2024 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=6589.322 - 220.333 - ( 1726.936 - max(0, 2398.213 - 3409.829+1726.936))
=5357.373

Invested Capital(Q: Jun. 2024 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=0 - 0 - ( 0 - max(0, 0 - 0+0))
=0

Note: The Operating Income data used here is four times the quarterly (Jun. 2024) data.

2. Joel Greenblatt's definition of Return on Capital:

Kohjin Bio Co's annualized ROC (Joel Greenblatt) % for the quarter that ended in Jun. 2024 is calculated as:

ROC (Joel Greenblatt) %(Q: Jun. 2024 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Mar. 2024  Q: Jun. 2024
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=930.188/( ( (2586.755 + max(925.219, 0)) + (0 + max(0, 0)) )/ 1 )
=930.188/( ( 3511.974 + 0 )/ 1 )
=930.188/3511.974
=26.49 %

where Working Capital is:

Working Capital(Q: Mar. 2024 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(685.313 + 683.01 + 252.448) - (220.333 + 0 + 475.219)
=925.219

Working Capital(Q: Jun. 2024 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(0 + 0 + 0) - (0 + 0 + 0)
=0

When net working capital is negative, 0 is used.

Note: The EBIT data used here is four times the quarterly (Jun. 2024) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Kohjin Bio Co's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %=EBIT (TTM)/Enterprise Value (Q: Jun. 2024 )
=625.141/7866.310
=7.95 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Kohjin Bio Co EBIT Related Terms

Thank you for viewing the detailed overview of Kohjin Bio Co's EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

Kohjin Bio Co Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Kohjin Bio Co Ltd (TSE:177A) » Definitions » EBIT
Comparable Companies
TSE:4579 TSE:4891 TSE:2370 TSE:3750 TSE:4564 TSE:4896 TSE:4893 TSE:2183 TSE:4571 TSE:206A VRTX ASX:CSL REGN XKRX:207940 XBRU:ARGX XBRU:UCB ALNY ONC BNTX XKRX:068270
Traded in Other Exchanges
N/A
Address
5-1-3 Chiyoda, Sakado, Saitama, JPN, 350-0214
Website
https://www.kohjin-bio.jp/en
Kohjin Bio Co Ltd is engaged in development, manufacture and sale of culture media (growing environments used for culturing microorganisms and cells) and contract manufacturing of processed cell products. It has manufacturing and sales of animal blood, sera, tissue culture media, media for microbiology testing, in vitro diagnostic agents, and cosmetics.

Kohjin Bio Co Headlines

No Headlines